Report cover image

Global Creatine Kinase Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 190 Pages
SKU # APRC20280379

Description

Summary

According to APO Research, the global Creatine Kinase market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Creatine Kinase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Creatine Kinase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Creatine Kinase market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Creatine Kinase is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Creatine Kinase market include Abbott, Roche, Siemens Healthcare, LSI Medience and Beckman Coulter, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Creatine Kinase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Creatine Kinase, also provides the sales of main regions and countries. Of the upcoming market potential for Creatine Kinase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Creatine Kinase sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Creatine Kinase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Creatine Kinase sales, projected growth trends, production technology, application and end-user industry.

Creatine Kinase Segment by Company

Abbott
Roche
Siemens Healthcare
LSI Medience
Beckman Coulter
Creatine Kinase Segment by Type

BB
MB
MM
Creatine Kinase Segment by Application

Hospital
Laboratory
Others
Creatine Kinase Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Colombia
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Creatine Kinase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Creatine Kinase market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Creatine Kinase significant trends, drivers, influence factors in global and regions.
6. To analyze Creatine Kinase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Creatine Kinase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Creatine Kinase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Creatine Kinase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Creatine Kinase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Creatine Kinase industry.
Chapter 3: Detailed analysis of Creatine Kinase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Creatine Kinase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Creatine Kinase in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Creatine Kinase Sales Value (2020-2031)
1.2.2 Global Creatine Kinase Sales Volume (2020-2031)
1.2.3 Global Creatine Kinase Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Creatine Kinase Market Dynamics
2.1 Creatine Kinase Industry Trends
2.2 Creatine Kinase Industry Drivers
2.3 Creatine Kinase Industry Opportunities and Challenges
2.4 Creatine Kinase Industry Restraints
3 Creatine Kinase Market by Company
3.1 Global Creatine Kinase Company Revenue Ranking in 2024
3.2 Global Creatine Kinase Revenue by Company (2020-2025)
3.3 Global Creatine Kinase Sales Volume by Company (2020-2025)
3.4 Global Creatine Kinase Average Price by Company (2020-2025)
3.5 Global Creatine Kinase Company Ranking (2023-2025)
3.6 Global Creatine Kinase Company Manufacturing Base and Headquarters
3.7 Global Creatine Kinase Company Product Type and Application
3.8 Global Creatine Kinase Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Creatine Kinase Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Creatine Kinase Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Creatine Kinase Market by Type
4.1 Creatine Kinase Type Introduction
4.1.1 BB
4.1.2 MB
4.1.3 MM
4.2 Global Creatine Kinase Sales Volume by Type
4.2.1 Global Creatine Kinase Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Creatine Kinase Sales Volume by Type (2020-2031)
4.2.3 Global Creatine Kinase Sales Volume Share by Type (2020-2031)
4.3 Global Creatine Kinase Sales Value by Type
4.3.1 Global Creatine Kinase Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Creatine Kinase Sales Value by Type (2020-2031)
4.3.3 Global Creatine Kinase Sales Value Share by Type (2020-2031)
5 Creatine Kinase Market by Application
5.1 Creatine Kinase Application Introduction
5.1.1 Hospital
5.1.2 Laboratory
5.1.3 Others
5.2 Global Creatine Kinase Sales Volume by Application
5.2.1 Global Creatine Kinase Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Creatine Kinase Sales Volume by Application (2020-2031)
5.2.3 Global Creatine Kinase Sales Volume Share by Application (2020-2031)
5.3 Global Creatine Kinase Sales Value by Application
5.3.1 Global Creatine Kinase Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Creatine Kinase Sales Value by Application (2020-2031)
5.3.3 Global Creatine Kinase Sales Value Share by Application (2020-2031)
6 Creatine Kinase Regional Sales and Value Analysis
6.1 Global Creatine Kinase Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Creatine Kinase Sales by Region (2020-2031)
6.2.1 Global Creatine Kinase Sales by Region: 2020-2025
6.2.2 Global Creatine Kinase Sales by Region (2026-2031)
6.3 Global Creatine Kinase Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Creatine Kinase Sales Value by Region (2020-2031)
6.4.1 Global Creatine Kinase Sales Value by Region: 2020-2025
6.4.2 Global Creatine Kinase Sales Value by Region (2026-2031)
6.5 Global Creatine Kinase Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Creatine Kinase Sales Value (2020-2031)
6.6.2 North America Creatine Kinase Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Creatine Kinase Sales Value (2020-2031)
6.7.2 Europe Creatine Kinase Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Creatine Kinase Sales Value (2020-2031)
6.8.2 Asia-Pacific Creatine Kinase Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Creatine Kinase Sales Value (2020-2031)
6.9.2 South America Creatine Kinase Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Creatine Kinase Sales Value (2020-2031)
6.10.2 Middle East & Africa Creatine Kinase Sales Value Share by Country, 2024 VS 2031
7 Creatine Kinase Country-level Sales and Value Analysis
7.1 Global Creatine Kinase Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Creatine Kinase Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Creatine Kinase Sales by Country (2020-2031)
7.3.1 Global Creatine Kinase Sales by Country (2020-2025)
7.3.2 Global Creatine Kinase Sales by Country (2026-2031)
7.4 Global Creatine Kinase Sales Value by Country (2020-2031)
7.4.1 Global Creatine Kinase Sales Value by Country (2020-2025)
7.4.2 Global Creatine Kinase Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Creatine Kinase Sales Value Growth Rate (2020-2031)
7.5.2 USA Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Creatine Kinase Sales Value Growth Rate (2020-2031)
7.6.2 Canada Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Creatine Kinase Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Creatine Kinase Sales Value Growth Rate (2020-2031)
7.8.2 Germany Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Creatine Kinase Sales Value Growth Rate (2020-2031)
7.9.2 France Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.9.3 France Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Creatine Kinase Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Creatine Kinase Sales Value Growth Rate (2020-2031)
7.11.2 Italy Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Creatine Kinase Sales Value Growth Rate (2020-2031)
7.12.2 Spain Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Creatine Kinase Sales Value Growth Rate (2020-2031)
7.13.2 Russia Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Creatine Kinase Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Creatine Kinase Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Creatine Kinase Sales Value Growth Rate (2020-2031)
7.16.2 China Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.16.3 China Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Creatine Kinase Sales Value Growth Rate (2020-2031)
7.17.2 Japan Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Creatine Kinase Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Creatine Kinase Sales Value Growth Rate (2020-2031)
7.19.2 India Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.19.3 India Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Creatine Kinase Sales Value Growth Rate (2020-2031)
7.20.2 Australia Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Creatine Kinase Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Creatine Kinase Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Creatine Kinase Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Creatine Kinase Sales Value Growth Rate (2020-2031)
7.24.2 Chile Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Creatine Kinase Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Creatine Kinase Sales Value Growth Rate (2020-2031)
7.26.2 Peru Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Creatine Kinase Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Creatine Kinase Sales Value Growth Rate (2020-2031)
7.28.2 Israel Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Creatine Kinase Sales Value Growth Rate (2020-2031)
7.29.2 UAE Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Creatine Kinase Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Creatine Kinase Sales Value Growth Rate (2020-2031)
7.31.2 Iran Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Creatine Kinase Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Creatine Kinase Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Creatine Kinase Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Creatine Kinase Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Abbott
8.1.1 Abbott Comapny Information
8.1.2 Abbott Business Overview
8.1.3 Abbott Creatine Kinase Sales, Value and Gross Margin (2020-2025)
8.1.4 Abbott Creatine Kinase Product Portfolio
8.1.5 Abbott Recent Developments
8.2 Roche
8.2.1 Roche Comapny Information
8.2.2 Roche Business Overview
8.2.3 Roche Creatine Kinase Sales, Value and Gross Margin (2020-2025)
8.2.4 Roche Creatine Kinase Product Portfolio
8.2.5 Roche Recent Developments
8.3 Siemens Healthcare
8.3.1 Siemens Healthcare Comapny Information
8.3.2 Siemens Healthcare Business Overview
8.3.3 Siemens Healthcare Creatine Kinase Sales, Value and Gross Margin (2020-2025)
8.3.4 Siemens Healthcare Creatine Kinase Product Portfolio
8.3.5 Siemens Healthcare Recent Developments
8.4 LSI Medience
8.4.1 LSI Medience Comapny Information
8.4.2 LSI Medience Business Overview
8.4.3 LSI Medience Creatine Kinase Sales, Value and Gross Margin (2020-2025)
8.4.4 LSI Medience Creatine Kinase Product Portfolio
8.4.5 LSI Medience Recent Developments
8.5 Beckman Coulter
8.5.1 Beckman Coulter Comapny Information
8.5.2 Beckman Coulter Business Overview
8.5.3 Beckman Coulter Creatine Kinase Sales, Value and Gross Margin (2020-2025)
8.5.4 Beckman Coulter Creatine Kinase Product Portfolio
8.5.5 Beckman Coulter Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Creatine Kinase Value Chain Analysis
9.1.1 Creatine Kinase Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Creatine Kinase Sales Mode & Process
9.2 Creatine Kinase Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Creatine Kinase Distributors
9.2.3 Creatine Kinase Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.